Functional assays, including in vitro experiments and in vivo experiments via a male BALB/c nude mouse orthotopic glioma model (<i>n</i> = 6/group), confirmed that PHF23 silencing inhibited glioma malignancy. This evidence concerns the gene PHF23 and central nervous system cancer.